PVLA Earnings & Financial Statements - Palvella Therapeutics, Inc. logo

PVLA Earnings & Financial Statements

Palvella Therapeutics, Inc.

$146.58
+$2.23(+1.54%)
45
Overall
40
Value
58
Tech
39
Quality
How is this score calculated?
Market Cap
$2.14B
Volume
118.89K
52W Range
$72.23 - $179.95
Target Price
$231.06

PVLA earnings and financial statements: Palvella Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.

PVLA Annual Financial Statements

PVLA income statement
Fiscal year20252024202320222021
Revenue--$42.81M$25.90M$31.42M
Operating income-$38.60M-$14.10M-$11.87M-$43.91M-$51.83M
EBITDA-$35.90M-$17.65M$18.69M-$32.52M-$46.96M
Net income-$41.72M-$17.43M$18.69M-$33.28M-$45.74M
EPS (diluted)$-3.71$-7.83$-21.60$-0.45$-0.71
PVLA balance sheet
Fiscal year20252024202320222021
Total assets$59.56M$88.23M$7.55M$95.49M$153.56M
Total liabilities$31.58M$25.63M$11.43M$67.56M$102.81M
Shareholders’ equity$27.98M$62.61M-$74.48M$27.93M$50.76M
Cash and equivalents$57.98M$83.60M$7.35M$38.63M$117.76M
Long-term debt$431.0K--$12.24M$13.84M
PVLA cash flow statement
Fiscal year20252024202320222021
Operating cash flow-$25.01M-$10.84M-$13.70M-$14.84M-$7.66M
Capital expenditure---$171.0K-$1.04M-$949.0K
Free cash flow-$25.01M-$10.84M-$13.70M-$14.84M-$8.61M
ABCD
1SymbolPriceChangeVol
2PVLA$146.58+1.5%118.89K
3
4
5
6

Get Palvella Therapeutics, Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.